Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
capecitabine (xeloda) (2 trials)
cisplatin (platinol) (2 trials)
gimeracil (1 trial)
oteracil (1 trial)
s-1 (1 trial)
tegafur (1 trial)
Stomach Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (6 total)